Elsevier Announces the Launch of Open Access Journal: New Negatives in Plant Science

July 8, 2014

AMSTERDAM, July 8, 2014 /PRNewswire/ –

Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical
and medical information, is pleased to announce the launch of an open access, online-only
journal: New Negatives in Plant Science
[http://www.journals.elsevier.com/new-negatives-in-plant-science ].

The journal will publish research focusing on negative, unexpected or controversial
results in fundamental plant sciences. Published work will include research articles and
short communications, as well as commentaries on previously published articles.

The journal is specifically interested in covering areas of molecular-cellular
biology, biochemistry, and -omics fields in algae and higher plants. The Editors of New
Negatives in Plant Science, Dr Thomas W. Okita of Washington State University and Dr Jose
A Olivares of Los Alamos National Laboratory, hope that the journal will help encourage
and drive scientific debate in basic plant sciences by sharing otherwise unpublished

The editors explain, “In published literature, more often than not we do not refer to
the negative, null, or unvarying measurements that do not support a current hypothesis or
accepted theory. We do this because of our cultural predispositions for positive
reinforcement. Yet, this information can be valuable to the scientific community in a
number of ways, for example by helping others to avoid repeating the same experiments as
well as encouraging new hypothesis building.”

Emma Granqvist, the publisher responsible for Elsevier’s Plant Sciences portfolio of
journals, said, “The journal aims to avoid publication bias, making all study results
widely available to the plant science community. We are delighted to be able to help
achieve this aim and are convinced New Negatives in Plant Science will be a strong
addition to Elsevier’s open access publications.”

The journal will use the article based publishing model, which allows for immediate
publication of the final version of a paper without waiting for other articles to be
compiled into a full issue.

For more information or to submit an article, go to:


About Open Access Publishing at Elsevier

Elsevier has been providing open access publishing options since 2005. Today,
researchers can choose to publish open access in over 1,600 established peer-reviewed
journals as well as over 100 full open access journals and these numbers will continue to
grow rapidly. All of Elsevier’s open access publications have been peer reviewed, ensuring
that the broader community not only reads the latest research but that it is factual,
original and of the highest quality and ethical standards. For more information about
Elsevier’s open access program, visit http://www.elsevier.com/openaccess.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the
performance of science, health, and technology professionals, empowering them to make
better decisions, deliver better care, and sometimes make groundbreaking discoveries that
advance the boundaries of knowledge and human progress. Elsevier provides web-based,
digital solutions – among them ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Elsevier Research Intelligence
[http://www.elsevier.com/online-tools/research-intelligence ] and ClinicalKey
[https://www.clinicalkey.com ] – and publishes nearly 2,200 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and over 25,000 book titles,
including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading provider of professional information solutions in the Science, Medical,
Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed
Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange),
RUK and ENL (New York Stock Exchange).

        Media contact
        Marije Hoogstrate

SOURCE Elsevier

Source: PR Newswire

comments powered by Disqus